在帕金森病不同阶段的皮质微观结构变化
Xueqin Bai1,2, Tao Guo1, Xiaojun Guan1
1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, No.88 Jiefang Road, Shangcheng District, Hangzhou, 310009, China.
Brain imaging and behavior
|September 27, 2024
概括
帕金森病导致大脑变化,早期阶段显示出减少的定向分散,晚期阶段表现出更广泛的微观结构退化. 这些大脑变化随着帕金森病的进展而恶化.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病.
- 皮层微结构变化与PD进展有关.
- 了解这些变化对于诊断和治疗至关重要.
研究的目的:
- 为了研究早期PD (EPD) 和中度到晚期PD (MLPD) 的皮质微结构变化.
- 为了将微观结构变化与疾病严重程度相关联.
主要方法:
- 149名PD患者和76名对照人接受了两扩散MRI.
- 使用神经元定向分散和密度成像 (NODDI) 模型来推导神经元密度指数 (NDI) 和定向分散指数 (ODI).
- 基于灰色物质的空间统计和部分相关性分析进行.
主要成果:
- 与对照组相比,EPD患者普遍呈现较低的ODI和区域较低的NDI.
- 患有MLPD的患者在ODI和NDI中表现出更广泛的减少.
- 在PD患者中较低的ODI与全球复合结果负相关.
结论:
- 帕金森病的特征是渐进的皮层微结构性退化.
- 减少神经元密度和方向分散是PD进展的关键指标.
- NODDI指标为PD的神经病理学提供了洞察力.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.5K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
